(PRWEB UK) 7 January 2013
According to the report US Proton Therapy Market Analysis to 2017, about 60% of all cancer patients undergo some sort of radiation therapy during their course of treatment. Despite advances in technology for radiation therapy, a majority of these patients suffer from side effects of traditional radiation treatment involved withprevalent radio therapy methods like X-Ray/IMRT etc.
In this context, Proton Therapy, the latest innovation in the field of radio-oncology, answers all of the problems related to radiation therapy. The technology is expected to eventually replace the traditional methods of radiotherapy in the future and thus, holds immense market potential for players in the industry.
The report, 'US Proton Therapy Market Analysis to 2017' provides an extensive research and in-depth analysis of the current status and future outlook of the US proton therapy market. A thorough analysis has been carried on the various parameters concerned with the existing and upcoming proton therapy centers in the US. The report offers state-wise potential for the industry players and provides conservative market estimates till 2017.